StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Propan-1,2,3-triyltrisheptanoat

Triheptanoin

HCID 69286
Neue Reaktion
Drucken
GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
620-67-7
Standard-SMILES
CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC
InChIKey
PJHKBYALYHRYSK-UHFFFAOYSA-N
Summenformel
C24H44O6
Durchschnittliche Molmasse
428,6 g/mol
Monoisotopische Masse
428,31378912

Überblick

Triheptanoin is a source of heptanoate fatty acids, which can be metabolized without the enzymes of long chain fatty acid oxidation. In clinical trials, patients with long chain fatty acid oxidation disorders (lc-FAODs) treated with triheptanoin are less likely to develop hypoglycemia, cardiomyopathy, rhabdomyolysis, and hepatomegaly. Complications in lc-FAOD patients are reduced from approximately 60% to approximately 10% with the addition of triheptanoin. Triheptanoin was granted FDA approval on 30 June 2020.

Namen und Bezeichner

Bevorzugter Name
Triheptanoin
IUPAC
2,3-di(heptanoyloxy)propyl heptanoate
Lokaler Name
Propan-1,2,3-triyltrisheptanoat
Englischer Name
TRIHEPTANOIN
Summenformel
C24H44O6
Molmasse
428.6

Namen und Synonyme

Triheptanoin620-67-7TrienanthoinTrioenanthoinTriheptylinGlycerol triheptanoateHeptanoin, tri-Triheptanoic glycerideDermofeel TC 7DojolviGLYCERYL TRIHEPTANOATEglyceroltriheptanoate
Weitere Namen anzeigen
C7 oilTRIOENANTHINTRIHEPTANIONtri-heptanoiC7 fatty acid
2,3-di(heptanoyloxy)propyl heptanoateUX007Dub thgDermofeel tc-7Radiamuls 2375Lanol 37 ttriheptanoinatriheptanoine

Datenbank-Bezeichner

CAS
620-67-7
PubChem CID
69286
DTXSID
DTXSID40862306
ChEMBL
CHEMBL4297585
UNII
2P6O7CFW5K
EC Number
210-647-2
Nikkaji
J53.997J

Eigenschaften

Berechnete Struktureigenschaften

XLogP
7,3
Polarare Oberfläche (TPSA)
78,9 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
6
Frei drehbare Bindungen
23
Schwere Atome
30
Formalladung
0
Komplexität
421

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Listed in ZINC15
Cosmetics · 2 Einträge

Cosmetic ingredients (Triheptanoin) -> CIR (Cosmetic Ingredient Review)

Skin conditioning; Surfactant

Human Drugs · 2 Einträge

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physikochemische Eigenschaften

Siedepunkt
200 °C · 200 °C(Press: 1 Torr)
Dichte
0.966 g/mL · 0.966 g/mL at 20 °C(lit.)
Brechungsindex
20 · n20/D 1.444
storage temp.
-20 °C, · Store at -20°C, protect from light
Löslichkeit
30 mg/ml; · DMF: 30 mg/ml; DMSO: 30 mg/ml; Ethanol: 30 mg/ml
Aggregatzustand
A liquid
Farbe
Colorless to light yellow
Stabilität
Stable. Incompatible with strong oxidizing agents.
Kosmetik-Inhaltsstoffe Funktionen
SKIN CONDITIONING - OCCLUSIVEVISCOSITY CONTROLLING
InChI
InChI=1S/C24H44O6/c1-4-7-10-13-16-22(25)28-19-21(30-24(27)18-15-12-9-6-3)20-29-23(26)17-14-11-8-5-2/h21H,4-20H2,1-3H3
InChIKey
PJHKBYALYHRYSK-UHFFFAOYSA-N
SMILES
C(OC(=O)CCCCCC)C(OC(=O)CCCCCC)COC(=O)CCCCCC
LogP
8.86 at · 8.86 at 22℃
CAS Datenbank
620 · 620-67-7
EPA chemische Informationen
1 · Heptanoic acid, 1,1',1''-(1,2,3-propanetriyl) ester (620-67-7)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

GHS-Klassifizierung

GHS Classification · 5 Einträge

This chemical does not meet GHS hazard criteria for 62.1% (64 of 103) of all reports.

Warning

H315 (37.9%): Causes skin irritation [Warning Skin corrosion/irritation]

P264, P273, P280, P302+P352, P321, P332+P317, P362+P364, P391, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 103 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Gefahrenhinweise

Regulatory Information · 3 Einträge

PMN - indicates a commenced PMN (Pre-Manufacture Notices) substance.

REACH registered substance: Propane-1,2,3-triyl trisheptanoate (EC: 210-647-2)

Triheptanoin: Does not have an individual approval but may be used under an appropriate group standard

Hazard Classes and CategoriesSkin Irrit. 2 (37.9%)

Toxikologische Informationen

Hepatotoxicity · 1 Eintrag

Serum enzyme elevations during triheptanoin therapy are frequent, mostly reflecting the underlying condition of muscle and hepatic accumulation of toxic fatty acid products and lack of adequate energy production. Elevations in CPK were present in 81%, ALT in 72% and AST in 68% of subjects treated in preregistration studies. The elevations were greater than 5 times the upper limit of normal (ULN) of CPK in 47%, ALT in 24% and AST in 15%. Nevertheless, the changes were not considered due to the triheptanoin or MCT therapy but rather to the underlying metabolic disorder and mitochondrial dysfunction. In small trials of triheptanoin in other genetic metabolic diseases, laboratory values were reported to be unchanged during supplementation. Since its approval and more widescale use, there have been no published cases of clinically apparent liver injury attributed to triheptanoin therapy, although its total clinical experience with its use has been limited.

Toxicity SummarySafe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org
Drug Induced Liver Injury · 6 Einträge

Drug Induced Liver Injury Rank (DILIrank 2.0)

Triheptanoin

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

Sicherheitsdaten

wgk
1
tsca
TSCA listed
RTECS-Nr.
MB2660000
risk_code
38
Toxizität
LD50 intravenous in mouse: 320mg/kg
hazard_code
Xi
Speicherklasse
11 - Combustible Solids

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 2 Einträge

A - Alimentary tract and metabolism

QA - Alimentary tract and metabolism

Protein BindingTriheptanoin is approximately 80% protein bound in plasma, likely serum albumin.
Pharmacodynamics · 1 Eintrag

Triheptanoin is a source of medium chain fatty acids for patients with lc-FAODs. It has a moderate duration of action and a wide therapeutic window. Patients should be counselled regarding the risk of feeding tube dysfunction and intestinal malabsorption due to pancreatic insufficiency.

Mechanism of Action · 1 Eintrag

Triheptanoin is a source of heptanoate fatty acids, which can be metabolized without the enzymes of long chain fatty acid oxidation. In clinical trials, patients with lc-FAODs treated with triheptanoin experienced improvements in hypoglycemia, cardiomyopathy, and rhabdomyolysis.

Biological Half-LifeDue to multiple peak concentrations of the heptanoate metabolite, the half life of triheptanoin could not be determined.
Metabolism/MetabolitesTriheptanoin is hydrolysed to heptanoate, which can be further metabolized to β-hydroxypentanoate or β-hydroxybutyrate.
FDA Pharmacological Classification · 6 Einträge

2P6O7CFW5K

TRIHEPTANOIN

Established Pharmacologic Class [EPC] - Medium-chain Triglyceride

Chemical Structure [CS] - Triglycerides

Triheptanoin is a Medium-chain Triglyceride.

TRIHEPTANOIN

Absorption, Distribution and Excretion · 3 Einträge

A single 0.3 g/kg dose of triheptanoin reaches a Cmax of 178.9 µmol/L, with a Tmax 0.5 h, and an AUC of 336.5 µmol\*h/L. A single 0.4 g/kg dose of triheptanoin reaches a Cmax of 259.1 µmol/L, with a Tmax 0.8 h, and an AUC of 569.1 µmol\*h/L.

Triheptanoin is minimally eliminated in the urine.

A single dose of 0.3 g/kg results in a mean apparent clearance of 6.05 L/h/kg for heptanoate. A single dose of 0.4 g/kg results in a mean apparent clearance of 4.31 L/h/kg for heptanoate.

Verwendung und Herstellung

UsesCIR ingredient: Triheptanoin
Household ProductsInformation on 3 consumer products that contain Triheptanoin in the following categories is provided:
Use ClassificationCosmetics -> Skin conditioning; Surfactant
General Manufacturing InformationHeptanoic acid, 1,1',1''-(1,2,3-propanetriyl) ester: ACTIVE

Anwendungen

Verwendentriheptanoin is a triglyceride that acts as a surfactant and skinconditioning agent, it also helps increase product viscosity. often used in cleansers, face and neck products, moisturizers and lipsticks.

Zugehörige Reaktionen

0
Reaktionsaufzeichnung erstellen
Noch keine zugehörigen Reaktionen

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung